A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) The FDA withdrew its approval for the use of all oral and parenteral drug products containing 25 milligrams or more of diethylstilbestrol per unit dose.[L43942]
Synonyms
trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol
(E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol
trans-Diethylstilboesterol
Stilboestrol
Diéthylstilbestrol
Dietilestilbestrol
trans-Diethylstilbesterol
Diethylstilbestrol diphosphate
Diethylstilbestrolum
DES
4,4'-dihydroxy-α,β-diethylstilbene
(E)-3,4-bis(4-hydroxyphenyl)-3-hexene
Diethylstilbestrol
α,α'-diethyl-(E)-4,4'-stilbenediol
Diethylstilbestrol diphosphate sodium
trans-Diethylstilbestrol
Brand Names
Stilboestrol Tab 0.5mg
Stilbestrol Tablets 1.0 mg
Stilbestrol Tablets 0.1 mg
Honvol Tablets 100mg
Stilbestrol Tab 1mg
Stilbestrol Tablets 0.5 mg
Stilboestrol Tab 0.1mg
Honvol Ampoules 250mg
Stilbestrol 1.0mg Tablet
Stilbestrol 0.5mg Tablet
Indication
Used in the treatment of prostate cancer. Previously used in the prevention of miscarriage or premature delivery in pregnant women prone to miscarriage or premature delivery.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
